283 related articles for article (PubMed ID: 21846853)
1. Use of radioactive iodine for thyroid cancer.
Haymart MR; Banerjee M; Stewart AK; Koenig RJ; Birkmeyer JD; Griggs JJ
JAMA; 2011 Aug; 306(7):721-8. PubMed ID: 21846853
[TBL] [Abstract][Full Text] [Related]
2. The relationship between extent of thyroid cancer surgery and use of radioactive iodine.
Haymart MR; Banerjee M; Yang D; Stewart AK; Doherty GM; Koenig RJ; Griggs JJ
Ann Surg; 2013 Aug; 258(2):354-8. PubMed ID: 23567930
[TBL] [Abstract][Full Text] [Related]
3. Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.
Schuessler KM; Banerjee M; Yang D; Stewart AK; Doherty GM; Haymart MR
Ann Surg Oncol; 2013 Mar; 20(3):733-8. PubMed ID: 23224826
[TBL] [Abstract][Full Text] [Related]
4. Disease severity and radioactive iodine use for thyroid cancer.
Haymart MR; Muenz DG; Stewart AK; Griggs JJ; Banerjee M
J Clin Endocrinol Metab; 2013 Feb; 98(2):678-86. PubMed ID: 23322816
[TBL] [Abstract][Full Text] [Related]
5. Application of the new American Thyroid Association guidelines leads to a substantial rate of completion total thyroidectomy to enable adjuvant radioactive iodine.
Kluijfhout WP; Pasternak JD; Drake FT; Beninato T; Shen WT; Gosnell JE; Suh I; C L; Duh QY
Surgery; 2017 Jan; 161(1):127-133. PubMed ID: 27855968
[TBL] [Abstract][Full Text] [Related]
6. Radioactive iodine remnant uptake after completion thyroidectomy: not such a complete cancer operation.
Oltmann SC; Schneider DF; Leverson G; Sivashanmugam T; Chen H; Sippel RS
Ann Surg Oncol; 2014 Apr; 21(4):1379-83. PubMed ID: 24378987
[TBL] [Abstract][Full Text] [Related]
7. Disparity in the use of adjuvant radioactive iodine ablation among high-risk papillary thyroid cancer patients.
Moten AS; Zhao H; Intenzo CM; Willis AI
Eur J Surg Oncol; 2019 Nov; 45(11):2090-2095. PubMed ID: 31253543
[TBL] [Abstract][Full Text] [Related]
8. Use of radioiodine-131 scan to measure influence of surgical discipline, practice, and volume on residual thyroid tissue after total thyroidectomy for differentiated thyroid carcinoma.
Song JSA; Moolman N; Burrell S; Rajaraman M; Bullock MJ; Trites J; Taylor SM; Rigby MH; Hart RD
Head Neck; 2018 Oct; 40(10):2129-2136. PubMed ID: 29756327
[TBL] [Abstract][Full Text] [Related]
9. Factors that influence radioactive iodine use for thyroid cancer.
Papaleontiou M; Banerjee M; Yang D; Sisson JC; Koenig RJ; Haymart MR
Thyroid; 2013 Feb; 23(2):219-24. PubMed ID: 23134514
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Survival Outcomes Following Postsurgical Radioactive Iodine Versus External Beam Radiation in Stage IV Differentiated Thyroid Carcinoma.
Yang Z; Flores J; Katz S; Nathan CA; Mehta V
Thyroid; 2017 Jul; 27(7):944-952. PubMed ID: 28446057
[TBL] [Abstract][Full Text] [Related]
11. Regional differences in opinions on adjuvant radioactive iodine treatment of thyroid carcinoma within Canada and the United States.
Sawka AM; Rotstein L; Brierley JD; Tsang RW; Thabane L; Gafni A; Straus S; Kamalanathan S; Zhao B; Goldstein DP; Rambaldini G; Ezzat S
Thyroid; 2007 Dec; 17(12):1235-42. PubMed ID: 17988197
[TBL] [Abstract][Full Text] [Related]
12. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
Scheffel RS; Zanella AB; Dora JM; Maia AL
Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
[TBL] [Abstract][Full Text] [Related]
13. Multilevel Factors Associated With More Intensive Use of Radioactive Iodine for Low-Risk Thyroid Cancer.
Wallner LP; Banerjee M; Reyes-Gastelum D; Hamilton AS; Ward KC; Lubitz C; Hawley ST; Haymart MR
J Clin Endocrinol Metab; 2021 May; 106(6):e2402-e2412. PubMed ID: 33687063
[TBL] [Abstract][Full Text] [Related]
14. Too Much of a Good Thing: Radioactive Iodine Ablation Use for Micropapillary Thyroid Carcinoma.
Chae AW; Martinez SR
Am Surg; 2018 May; 84(5):637-643. PubMed ID: 29966562
[TBL] [Abstract][Full Text] [Related]
15. Concordance in postsurgical radioactive iodine therapy recommendations between Watson for Oncology and clinical practice in patients with differentiated thyroid carcinoma.
Kim M; Kim BH; Kim JM; Kim EH; Kim K; Pak K; Jeon YK; Kim SS; Park H; Kang T; Lee BJ; Kim IJ
Cancer; 2019 Aug; 125(16):2803-2809. PubMed ID: 31216369
[TBL] [Abstract][Full Text] [Related]
16. The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.
Haymart MR; Banerjee M; Yang D; Stewart AK; Koenig RJ; Griggs JJ
Cancer; 2013 Jan; 119(2):259-65. PubMed ID: 22744940
[TBL] [Abstract][Full Text] [Related]
17. Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer.
Jacobs D; Breen CT; Pucar D; Holt EH; Judson BL; Mehra S
Thyroid; 2021 Feb; 31(2):272-279. PubMed ID: 32811347
[No Abstract] [Full Text] [Related]
18. The impact of radioactive iodine treatment on survival among papillary thyroid cancer patients according to the 7th and 8th editions of the AJCC/TNM staging system: a SEER-based study.
Liu X; Fan Y; Liu Y; He X; Zheng X; Tan J; Jia Q; Meng Z
Updates Surg; 2020 Sep; 72(3):871-884. PubMed ID: 32342347
[TBL] [Abstract][Full Text] [Related]
19. The impact of socioeconomic status on the use of adjuvant radioactive iodine for papillary thyroid cancer.
Zevallos JP; Xu L; Yiu Y
Thyroid; 2014 Apr; 24(4):758-63. PubMed ID: 24378070
[TBL] [Abstract][Full Text] [Related]
20. Radioactive iodine in differentiated thyroid cancer: a national database perspective.
Orosco RK; Hussain T; Noel JE; Chang DC; Dosiou C; Mittra E; Divi V; Orloff LA
Endocr Relat Cancer; 2019 Oct; 26(10):795-802. PubMed ID: 31443087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
